Simon Breitler

Title: Simon Breitler: Innovator in Oligonucleotide Conjugates

Introduction

Simon Breitler is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of oligonucleotide chemistry, holding a total of 3 patents. His work focuses on innovative processes that enhance the preparation of GalNAc phosphoramidite epimers and oligonucleotide conjugates.

Latest Patents

Breitler's latest patents include a process for the preparation of GalNAc phosphoramidite epimers. This invention involves a method for creating a GalNAc phosphoramidite epimer of a specific formula, which includes various hydroxy protecting groups and integers that define the structure. Additionally, he has developed a process for the preparation of GalNAc oligonucleotide conjugates. This process entails the coupling of a GalNAc cluster compound with an oligonucleotide, utilizing an O-dicarboximidouronium salt as a coupling agent.

Career Highlights

Throughout his career, Simon Breitler has worked with prominent companies in the pharmaceutical and biotechnology sectors, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. His expertise in oligonucleotide chemistry has positioned him as a valuable asset in these organizations.

Collaborations

Breitler has collaborated with esteemed colleagues such as Kurt Puentener and Joerg Lill. These partnerships have furthered his research and development efforts in the field of oligonucleotide conjugates.

Conclusion

Simon Breitler's innovative work in the preparation of GalNAc phosphoramidite epimers and oligonucleotide conjugates showcases his significant contributions to the field of chemistry. His patents and collaborations reflect his dedication to advancing scientific knowledge and technology.